Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
245.02
+1.86 (+0.76%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Resmed Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Via
The Motley Fool
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
April 17, 2024
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
April 15, 2024
Via
Benzinga
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
April 08, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Via
Benzinga
Why NYSE:RMD qualifies as a good dividend investing stock.
April 08, 2024
Why the dividend investor may take a look at RESMED INC (NYSE:RMD).
Via
Chartmill
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
March 27, 2024
Via
Benzinga
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
March 28, 2024
Via
Benzinga
Peering Into ResMed's Recent Short Interest
March 26, 2024
Via
Benzinga
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast
March 21, 2024
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining...
Via
Talk Markets
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
March 06, 2024
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.
Via
Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
February 12, 2024
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals.
Via
Chartmill
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
February 22, 2024
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
Via
The Motley Fool
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
Cracking The Code: Understanding Analyst Reviews For ResMed
January 25, 2024
Via
Benzinga
Why ResMed Stock Is Jumping Today
January 25, 2024
The medical device maker beat expectations with its latest quarterly results.
Via
The Motley Fool
Recap: ResMed Q2 Earnings
January 24, 2024
Via
Benzinga
MatrixCare Earns Three 2024 Best in KLAS Awards
February 07, 2024
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent
From
MatrixCare
Via
GlobeNewswire
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
February 01, 2024
Via
Benzinga
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
January 25, 2024
ResMed reported better-than-expected sales and adjusted earnings.
Via
Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
January 25, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
ResMed's Earnings: A Preview
January 23, 2024
Via
Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
January 17, 2024
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics.
Via
Chartmill
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation.
Via
InvestorPlace
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
January 12, 2024
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.